EU pharmaceutical legislation revisions: what are the implications for biopharma?
European Pharmaceutical Review
DECEMBER 20, 2023
In October 2023, the European Parliament (EP) proposed revisions to the European Commission proposals with diverging views on various topics set out through two documents. In October 2023, the European Parliament (EP) proposed revisions to the European Commission proposals with diverging views on various topics set out through two documents.
Let's personalize your content